Optimi Health Confirms Presenting Sponsorship at the 4th Annual Psychedelic Therapeutics and Drug Development Conference
28. März 2024 07:30 ET
|
Optimi Health Corp.
Optimi Health secures Presenting Sponsorship at the highly anticipated 4th Annual Psychedelic Therapeutics and Drug Development Conference in Boston, MA.
Pasithea Therapeutics Announces Completion of GMP Manufacturing for PAS-004
29. Juni 2023 08:29 ET
|
Pasithea
PALO ALTO, Calif. and MIAMI, June 29, 2023 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the discovery, research,...
GAIA BioMedicine and TreeFrog Therapeutics Announce Collaboration for the Expansion of Allogeneic NK-like Cells Against Solid Tumors
15. Februar 2023 10:00 ET
|
TreeFrog Therapeutics
FUKUOKA, Japan and BORDEAUX, France, Feb. 15, 2023 (GLOBE NEWSWIRE) -- GAIA BioMedicine, a Japan-based clinical-stage company pioneering allogeneic NK-like cell therapies against solid tumors, and...
Forecyte Bio's Grand Opening of the CGMP Facility in Maryland
17. Januar 2023 06:00 ET
|
Forecyte Bio
FREDERICK, Md., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Forecyte Bio, a new global leader in cell and gene therapy contract development and manufacturing, officially opened its 17,000 square feet,...
Revolutionary progress made in the inaugural year of the Panacea Cannabinoid Research Center at Colorado State University
26. Oktober 2022 11:57 ET
|
Panacea Life Sciences Holdings, Inc.
GOLDEN, Colo., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Panacea Life Sciences Holdings, Inc. (OTCQB:PLSH) (“Panacea” or the “Company”), a Colorado, USA-based cannabinoid research and certified GMP...
Invectys appoints Jian Cao, Ph.D., as Vice President, Pharmaceutical Development
01. März 2022 09:15 ET
|
Invectys, Inc.
Houston, Texas, USA, March 01, 2022 (GLOBE NEWSWIRE) -- Invectys, Inc. of Houston, Texas, a clinical stage immunotherapy company dedicated to the development of a next generation of therapies to...
Aldevron Releases GMP-Grade SpyFi™ Cas9 Nuclease
12. März 2019 08:05 ET
|
Aldevron
FARGO, ND, March 12, 2019 (GLOBE NEWSWIRE) -- Aldevron, a leading contract development and manufacturing organization serving the biotech industry, announces the release of GMP SpyFi Cas9 Nuclease...
Novacap to expand its pharmaceutical offering in the U.S. with the acquisition of PCI Synthesis
20. Juni 2018 12:03 ET
|
PCI Synthesis; Novacap
LYON, France and NEWBURYPORT, Mass., June 20, 2018 (GLOBE NEWSWIRE) -- Novacap, a worldwide player in pharmaceutical synthesis and advanced specialties, announced today that it has signed an...
PCI Synthesis Identifies Trends Affecting the Generic Drugs Sector in 2018
18. Dezember 2017 09:15 ET
|
PCI Synthesis
NEWBURYPORT, Mass., Dec. 18, 2017 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...